ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,705Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 103

$340K Total Retail Price of All Prescriptions

Rank: 5 out of 103

445 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 445 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

11% of this provider’s 445 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 6,179 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
LEVOTHYROXINE SODIUM 517 425 1 1
OMEPRAZOLE 277 195 2 5
SIMVASTATIN 271 230 3 3
AMLODIPINE BESYLATE 262 257 4 7
LISINOPRIL 253 232 5 2
FUROSEMIDE 197 142 6 6
HYDROCODONE-ACETAMINOPHEN 195 143 S3 7 4
CARVEDILOL 167 163 8 16
HYDROCHLOROTHIAZIDE 160 136 9 8
CITALOPRAM HBR 150 123 10 15
METFORMIN HCL 144 111 11 9
WARFARIN SODIUM 143 125 12 10
SYNTHROID 140 140 13 43
ATORVASTATIN CALCIUM 138 129 14 33
CIPROFLOXACIN HCL 131 111 15 34
METOPROLOL SUCCINATE 121 97 16 12
LOSARTAN POTASSIUM 117 93 17 14
TRAMADOL HCL 105 85 18 45
METOPROLOL TARTRATE 103 75 19 11
DIOVAN 95 72 20 53
AZITHROMYCIN 73 53 21 17
PROMETHAZINE HCL 68 0 R 22 98
POTASSIUM CHLORIDE 67 49 23 13
GABAPENTIN 64 36 24 18
ZOLPIDEM TARTRATE 62 53 25 23
OXYCODONE HCL 60 41 S2 26 21
BENAZEPRIL HCL 59 50 27 72
CYMBALTA 59 45 27 47
MELOXICAM 59 50 27 26
SERTRALINE HCL 57 51 30 28
BUPROPION XL 57 40 30 114
SYMBICORT 55 47 32 46
CRESTOR 53 51 33 39
ACTOS 53 53 33 122
CYCLOBENZAPRINE HCL 52 14 R 35 74
ADVAIR DISKUS 51 35 36 24
JANUVIA 51 50 36 124
SPIRIVA 50 39 38 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 25, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.